Imperative Care

Imperative Care has multiple FDA-cleared products for the treatment of ischemic and hemorrhagic stroke, as well as peripheral vascular diseases. Over 30,000 patients have been treated with its devices. The company is running large multicenter clinical trials such as the Imperative Trial and pivotal SYMPHONY‑PE Study to validate its technologies. Its Zoom Stroke Solution is recognized for enabling rapid clot removal and vessel reperfusion within minutes, aiming to improve patient outcomes after stroke. The Vascular business has two FDA-cleared products—Symphony and Prodigy—for venous and peripheral arterial thrombectomy; both are commercially available or launching soon in the U.S.